Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvon Cormier

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Plos One|August 23, 2011
Immunogenic properties of archaeal species found in bioaerosolsPascale Blais Lecours, Caroline Duchaine, Michel Taillefer, et al.
Journal of Leukocyte Biology|February 10, 2007
Modulation of eosinophil activation in vitro by a nicotinic receptor agonistMarie-Renée Blanchet, Anick Langlois, Evelyne Israël-Assayag, et al.
Canadian Journal of Microbiology|May 15, 2007
Identification of mycobacteria in peat moss processing plants: application of molecular biology approachesMarie-Pierre Cayer, Marc Veillette, Pascal Pageau, et al.
Canadian Respiratory Journal|August 8, 2015
Effects of ASM-024, a modulator of acetylcholine receptor function, on airway responsiveness and allergen-induced responses in patients with mild asthmaLouis-Philippe Boulet, Gail M Gauvreau, Donald W Cockcroft, et al.
American Journal of Respiratory and Critical Care Medicine|June 7, 2011
CD34 is required for dendritic cell trafficking and pathology in murine hypersensitivity pneumonitisMarie-Renée Blanchet, Jami L Bennett, Matthew J Gold, et al.
Journal of Cancer Research and Clinical Oncology|July 12, 2011
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trialCharles Butts, Andrew Maksymiuk, Glenwood Goss, et al.
American Journal of Respiratory and Critical Care Medicine|July 5, 2003
Clinical diagnosis of hypersensitivity pneumonitisYves Lacasse, Moises Selman, Ulrich Costabel, et al.
International Archives of Allergy and Immunology|January 8, 2009
Classification of hypersensitivity pneumonitis: a hypothesisYves Lacasse, Moises Selman, Ulrich Costabel, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2009
Toll-like receptor 4 variants reduce airway response in human subjects at high endotoxin levels in a swine facilityAmbikaipakan Senthilselvan, James A Dosman, Liliane Chénard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2011
Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancerJanessa J Laskin, Garth Nicholas, Christopher Lee, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Plos One|August 23, 2011
Immunogenic properties of archaeal species found in bioaerosolsPascale Blais Lecours, Caroline Duchaine, Michel Taillefer, et al.
Journal of Leukocyte Biology|February 10, 2007
Modulation of eosinophil activation in vitro by a nicotinic receptor agonistMarie-Renée Blanchet, Anick Langlois, Evelyne Israël-Assayag, et al.
Canadian Journal of Microbiology|May 15, 2007
Identification of mycobacteria in peat moss processing plants: application of molecular biology approachesMarie-Pierre Cayer, Marc Veillette, Pascal Pageau, et al.
Canadian Respiratory Journal|August 8, 2015
Effects of ASM-024, a modulator of acetylcholine receptor function, on airway responsiveness and allergen-induced responses in patients with mild asthmaLouis-Philippe Boulet, Gail M Gauvreau, Donald W Cockcroft, et al.
American Journal of Respiratory and Critical Care Medicine|June 7, 2011
CD34 is required for dendritic cell trafficking and pathology in murine hypersensitivity pneumonitisMarie-Renée Blanchet, Jami L Bennett, Matthew J Gold, et al.
Journal of Cancer Research and Clinical Oncology|July 12, 2011
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trialCharles Butts, Andrew Maksymiuk, Glenwood Goss, et al.
American Journal of Respiratory and Critical Care Medicine|July 5, 2003
Clinical diagnosis of hypersensitivity pneumonitisYves Lacasse, Moises Selman, Ulrich Costabel, et al.
International Archives of Allergy and Immunology|January 8, 2009
Classification of hypersensitivity pneumonitis: a hypothesisYves Lacasse, Moises Selman, Ulrich Costabel, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2009
Toll-like receptor 4 variants reduce airway response in human subjects at high endotoxin levels in a swine facilityAmbikaipakan Senthilselvan, James A Dosman, Liliane Chénard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2011
Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancerJanessa J Laskin, Garth Nicholas, Christopher Lee, et al.
Pageof 6